n subjective symptoms. We sincerely hope that Avarept® will contribute to making the daily lives of individual patients more comfortable.” Tomokazu Matsusue, “Executive Managing Officer, Head of Busin...
https://www.senju.co.jp/system/files/content_news/2026-04/ENG_20260406_0.pdf